US Stock MarketDetailed Quotes

PMVP PMV Pharmaceuticals

Watchlist
  • 1.250
  • +0.030+2.46%
Close Mar 11 16:00 ET
  • 1.250
  • 0.0000.00%
Post 16:00 ET
64.92MMarket Cap-1.10P/E (TTM)

PMV Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments
-16.55%169.45M
-16.55%169.45M
-9.45%182.84M
13.81%212.92M
-13.73%197.94M
-15.76%203.06M
-15.76%203.06M
-22.00%201.92M
-32.57%187.09M
-18.93%229.43M
-Cash and cash equivalents
8.41%40.88M
8.41%40.88M
-6.24%48.81M
-28.86%48.53M
-66.66%47.65M
-65.18%37.71M
-65.18%37.71M
-47.86%52.06M
-21.68%68.21M
23.47%142.94M
-Short-term investments
-22.24%128.58M
-22.24%128.58M
-10.56%134.03M
38.29%164.39M
73.76%150.29M
24.55%165.35M
24.55%165.35M
-5.75%149.86M
-37.55%118.88M
-48.28%86.49M
Restricted cash
--0
--0
0.00%822K
0.00%822K
0.00%822K
0.00%822K
0.00%822K
0.00%822K
0.00%822K
0.00%822K
Other current assets
75.75%6.2M
75.75%6.2M
133.06%5.96M
101.60%5.05M
22.40%3.7M
-31.19%3.53M
-31.19%3.53M
-53.50%2.56M
-30.62%2.5M
-28.47%3.02M
Total current assets
-15.31%175.66M
-15.31%175.66M
-7.64%189.62M
14.90%218.79M
-13.21%202.46M
-16.03%207.41M
-16.03%207.41M
-22.58%205.3M
-32.45%190.41M
-19.01%233.28M
Non current assets
Net PPE
-91.85%1.55M
-91.85%1.55M
-4.29%18.54M
-6.53%18.57M
-6.16%19.11M
-7.06%19.05M
-7.06%19.05M
-0.69%19.37M
8.01%19.87M
36.02%20.37M
-Gross PPE
-86.50%3.01M
-86.50%3.01M
1.37%22.58M
-0.07%22.57M
0.11%22.75M
-1.59%22.32M
-1.59%22.32M
3.10%22.28M
10.59%22.59M
34.24%22.72M
-Accumulated depreciation
55.35%-1.46M
55.35%-1.46M
-38.99%-4.05M
-47.03%-4.01M
-54.29%-3.63M
-49.73%-3.27M
-49.73%-3.27M
-38.09%-2.91M
-33.92%-2.72M
-20.59%-2.35M
Investments and advances
-45.72%13.84M
-45.72%13.84M
-58.28%15.1M
--0
--15.12M
922.24%25.51M
922.24%25.51M
--36.18M
--31.76M
--0
Other non current assets
23.68%235K
23.68%235K
34.44%242K
0.55%182K
-42.04%182K
-39.30%190K
-39.30%190K
-41.37%180K
-41.23%181K
42.08%314K
Total non current assets
-65.07%15.63M
-65.07%15.63M
-39.22%33.88M
-63.81%18.75M
66.41%34.42M
92.01%44.74M
92.01%44.74M
181.36%55.73M
177.04%51.8M
-23.31%20.68M
Total assets
-24.14%191.29M
-24.14%191.29M
-14.38%223.5M
-1.93%237.54M
-6.73%236.88M
-6.72%252.15M
-6.72%252.15M
-8.41%261.03M
-19.41%242.22M
-19.38%253.96M
Liabilities
Current liabilities
Payables
103.24%6.58M
103.24%6.58M
22.94%2.06M
29.92%4.53M
-51.58%859K
8.04%3.24M
8.04%3.24M
-65.23%1.68M
4.21%3.49M
-63.53%1.77M
-accounts payable
103.24%6.58M
103.24%6.58M
22.94%2.06M
29.92%4.53M
-51.58%859K
8.04%3.24M
8.04%3.24M
-65.23%1.68M
4.21%3.49M
-63.53%1.77M
Current accrued expenses
-55.27%2.43M
-55.27%2.43M
18.79%6.26M
-48.25%2.7M
21.08%8.1M
23.37%5.44M
23.37%5.44M
51.55%5.27M
1.58%5.22M
39.24%6.69M
Current debt and capital lease obligation
-58.69%352K
-58.69%352K
--1.24M
6,294.44%1.15M
213.17%880K
61.36%852K
61.36%852K
----
-95.30%18K
8.91%281K
-Current capital lease obligation
-58.69%352K
-58.69%352K
--1.24M
6,294.44%1.15M
213.17%880K
61.36%852K
61.36%852K
--0
-95.30%18K
8.91%281K
Current liabilities
2.43%14.37M
2.43%14.37M
26.57%13.56M
-0.54%11.39M
13.86%12.06M
29.51%14.03M
29.51%14.03M
-8.06%10.72M
0.56%11.45M
-9.37%10.59M
Non current liabilities
Long term debt and capital lease obligation
-93.26%838K
-93.26%838K
-5.32%12.02M
-8.65%11.84M
-7.99%12.14M
-7.54%12.43M
-7.54%12.43M
4.65%12.7M
6.13%12.96M
14.96%13.2M
-Long term capital lease obligation
-93.26%838K
-93.26%838K
-5.32%12.02M
-8.65%11.84M
-7.99%12.14M
-7.54%12.43M
-7.54%12.43M
4.65%12.7M
6.13%12.96M
14.96%13.2M
Total non current liabilities
-93.26%838K
-93.26%838K
-5.32%12.02M
-8.65%11.84M
-7.99%12.14M
-7.54%12.43M
-7.54%12.43M
4.65%12.7M
6.13%12.96M
14.96%13.2M
Total liabilities
-42.53%15.21M
-42.53%15.21M
9.28%25.59M
-4.85%23.22M
1.74%24.2M
8.99%26.46M
8.99%26.46M
-1.58%23.42M
3.45%24.41M
2.69%23.79M
Shareholders'equity
Share capital
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
-common stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-18.94%-368.71M
-18.94%-368.71M
-17.49%-345.71M
-17.61%-326.49M
-25.02%-325.27M
-28.61%-310M
-28.61%-310M
-32.72%-294.25M
-36.44%-277.61M
-39.76%-260.17M
Paid-in capital
1.72%544.65M
1.72%544.65M
2.07%543.21M
9.13%540.99M
9.71%538.08M
9.84%535.47M
9.84%535.47M
9.98%532.21M
2.97%495.74M
2.46%490.46M
Gains losses not affecting retained earnings
-37.95%139K
-37.95%139K
215.49%410K
43.60%-185K
-11.21%-129K
150.34%224K
150.34%224K
65.37%-355K
67.94%-328K
82.58%-116K
Total stockholders'equity
-21.98%176.08M
-21.98%176.08M
-16.71%197.91M
-1.60%214.32M
-7.60%212.68M
-8.27%225.69M
-8.27%225.69M
-9.03%237.61M
-21.36%217.81M
-21.13%230.17M
Total equity
-21.98%176.08M
-21.98%176.08M
-16.71%197.91M
-1.60%214.32M
-7.60%212.68M
-8.27%225.69M
-8.27%225.69M
-9.03%237.61M
-21.36%217.81M
-21.13%230.17M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments -16.55%169.45M-16.55%169.45M-9.45%182.84M13.81%212.92M-13.73%197.94M-15.76%203.06M-15.76%203.06M-22.00%201.92M-32.57%187.09M-18.93%229.43M
-Cash and cash equivalents 8.41%40.88M8.41%40.88M-6.24%48.81M-28.86%48.53M-66.66%47.65M-65.18%37.71M-65.18%37.71M-47.86%52.06M-21.68%68.21M23.47%142.94M
-Short-term investments -22.24%128.58M-22.24%128.58M-10.56%134.03M38.29%164.39M73.76%150.29M24.55%165.35M24.55%165.35M-5.75%149.86M-37.55%118.88M-48.28%86.49M
Restricted cash --0--00.00%822K0.00%822K0.00%822K0.00%822K0.00%822K0.00%822K0.00%822K0.00%822K
Other current assets 75.75%6.2M75.75%6.2M133.06%5.96M101.60%5.05M22.40%3.7M-31.19%3.53M-31.19%3.53M-53.50%2.56M-30.62%2.5M-28.47%3.02M
Total current assets -15.31%175.66M-15.31%175.66M-7.64%189.62M14.90%218.79M-13.21%202.46M-16.03%207.41M-16.03%207.41M-22.58%205.3M-32.45%190.41M-19.01%233.28M
Non current assets
Net PPE -91.85%1.55M-91.85%1.55M-4.29%18.54M-6.53%18.57M-6.16%19.11M-7.06%19.05M-7.06%19.05M-0.69%19.37M8.01%19.87M36.02%20.37M
-Gross PPE -86.50%3.01M-86.50%3.01M1.37%22.58M-0.07%22.57M0.11%22.75M-1.59%22.32M-1.59%22.32M3.10%22.28M10.59%22.59M34.24%22.72M
-Accumulated depreciation 55.35%-1.46M55.35%-1.46M-38.99%-4.05M-47.03%-4.01M-54.29%-3.63M-49.73%-3.27M-49.73%-3.27M-38.09%-2.91M-33.92%-2.72M-20.59%-2.35M
Investments and advances -45.72%13.84M-45.72%13.84M-58.28%15.1M--0--15.12M922.24%25.51M922.24%25.51M--36.18M--31.76M--0
Other non current assets 23.68%235K23.68%235K34.44%242K0.55%182K-42.04%182K-39.30%190K-39.30%190K-41.37%180K-41.23%181K42.08%314K
Total non current assets -65.07%15.63M-65.07%15.63M-39.22%33.88M-63.81%18.75M66.41%34.42M92.01%44.74M92.01%44.74M181.36%55.73M177.04%51.8M-23.31%20.68M
Total assets -24.14%191.29M-24.14%191.29M-14.38%223.5M-1.93%237.54M-6.73%236.88M-6.72%252.15M-6.72%252.15M-8.41%261.03M-19.41%242.22M-19.38%253.96M
Liabilities
Current liabilities
Payables 103.24%6.58M103.24%6.58M22.94%2.06M29.92%4.53M-51.58%859K8.04%3.24M8.04%3.24M-65.23%1.68M4.21%3.49M-63.53%1.77M
-accounts payable 103.24%6.58M103.24%6.58M22.94%2.06M29.92%4.53M-51.58%859K8.04%3.24M8.04%3.24M-65.23%1.68M4.21%3.49M-63.53%1.77M
Current accrued expenses -55.27%2.43M-55.27%2.43M18.79%6.26M-48.25%2.7M21.08%8.1M23.37%5.44M23.37%5.44M51.55%5.27M1.58%5.22M39.24%6.69M
Current debt and capital lease obligation -58.69%352K-58.69%352K--1.24M6,294.44%1.15M213.17%880K61.36%852K61.36%852K-----95.30%18K8.91%281K
-Current capital lease obligation -58.69%352K-58.69%352K--1.24M6,294.44%1.15M213.17%880K61.36%852K61.36%852K--0-95.30%18K8.91%281K
Current liabilities 2.43%14.37M2.43%14.37M26.57%13.56M-0.54%11.39M13.86%12.06M29.51%14.03M29.51%14.03M-8.06%10.72M0.56%11.45M-9.37%10.59M
Non current liabilities
Long term debt and capital lease obligation -93.26%838K-93.26%838K-5.32%12.02M-8.65%11.84M-7.99%12.14M-7.54%12.43M-7.54%12.43M4.65%12.7M6.13%12.96M14.96%13.2M
-Long term capital lease obligation -93.26%838K-93.26%838K-5.32%12.02M-8.65%11.84M-7.99%12.14M-7.54%12.43M-7.54%12.43M4.65%12.7M6.13%12.96M14.96%13.2M
Total non current liabilities -93.26%838K-93.26%838K-5.32%12.02M-8.65%11.84M-7.99%12.14M-7.54%12.43M-7.54%12.43M4.65%12.7M6.13%12.96M14.96%13.2M
Total liabilities -42.53%15.21M-42.53%15.21M9.28%25.59M-4.85%23.22M1.74%24.2M8.99%26.46M8.99%26.46M-1.58%23.42M3.45%24.41M2.69%23.79M
Shareholders'equity
Share capital --0--0--0--0--0--0--0--0--0--0
-common stock --0--0--0--0--0--0--0--0--0--0
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -18.94%-368.71M-18.94%-368.71M-17.49%-345.71M-17.61%-326.49M-25.02%-325.27M-28.61%-310M-28.61%-310M-32.72%-294.25M-36.44%-277.61M-39.76%-260.17M
Paid-in capital 1.72%544.65M1.72%544.65M2.07%543.21M9.13%540.99M9.71%538.08M9.84%535.47M9.84%535.47M9.98%532.21M2.97%495.74M2.46%490.46M
Gains losses not affecting retained earnings -37.95%139K-37.95%139K215.49%410K43.60%-185K-11.21%-129K150.34%224K150.34%224K65.37%-355K67.94%-328K82.58%-116K
Total stockholders'equity -21.98%176.08M-21.98%176.08M-16.71%197.91M-1.60%214.32M-7.60%212.68M-8.27%225.69M-8.27%225.69M-9.03%237.61M-21.36%217.81M-21.13%230.17M
Total equity -21.98%176.08M-21.98%176.08M-16.71%197.91M-1.60%214.32M-7.60%212.68M-8.27%225.69M-8.27%225.69M-9.03%237.61M-21.36%217.81M-21.13%230.17M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.